Top Page
Nova Minerals
(OTC:NVA)
Nova Minerals (NVA) vs. iShares MSCI Australia ETF (EWA)
Nova Minerals Business Overview & Revenue Model
Nova Minerals Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -1.66M | -7.05M | 0.00 | 47.42K | 0.00 | 0.00 |
| Gross Profit | -1.92M | -7.05M | -592.00K | -456.90K | -351.00K | -206.00K |
| EBITDA | -7.12M | -9.30M | -13.68M | -3.57M | 34.73M | -3.14M |
| Net Income | -11.02M | -11.02M | -16.28M | -11.48M | 34.69M | -3.13M |
Balance Sheet | ||||||
| Total Assets | 112.54M | 112.54M | 107.25M | 122.34M | 108.33M | 56.87M |
| Cash, Cash Equivalents and Short-Term Investments | 9.08M | 9.08M | 3.15M | 19.24M | 21.28M | 15.52M |
| Total Debt | 0.00 | 0.00 | 7.06M | 6.53M | 862.37K | 862.37K |
| Total Liabilities | 2.69M | 2.69M | 8.86M | 8.95M | 4.00M | 4.29M |
| Stockholders Equity | 102.16M | 102.16M | 90.70M | 105.60M | 96.75M | 46.78M |
Cash Flow | ||||||
| Free Cash Flow | -11.38M | -13.39M | -16.32M | -26.94M | -28.71M | -23.18M |
| Operating Cash Flow | -6.41M | -7.64M | -3.67M | -3.08M | -2.86M | -2.14M |
| Investing Cash Flow | -4.97M | 4.12M | -13.32M | -24.14M | -3.96M | -21.06M |
| Financing Cash Flow | 8.50M | 9.79M | 986.89K | 25.16M | 11.15M | 34.88M |
Nova Minerals Technical Analysis
Nova Minerals Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | AU$140.22M | 11.02 | 8.79% | ― | 15.32% | 10.05% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | AU$215.05M | -21.79 | -20.60% | ― | ― | 7.28% | |
46 Neutral | AU$137.55M | -22.14 | -8.25% | ― | ― | -55.56% | |
45 Neutral | AU$416.45M | -23.89 | -11.04% | ― | ― | 50.26% | |
44 Neutral | AU$435.04M | -5.70 | -84.61% | ― | 149.43% | 1.20% |
Nova Minerals Corporate Events
Nova Minerals Limited has announced a proposed issue of up to 40,410,540 new ordinary fully paid shares via a placement or similar capital-raising mechanism, with the issue scheduled for 19 December 2025. The move represents a significant capital-raising initiative that could strengthen the company’s balance sheet, provide funding flexibility for future operational or exploration activities, and potentially dilute existing shareholders while expanding the investor base and enhancing the company’s financial capacity within the mining sector.
Nova Minerals has priced an underwritten public offering of 2,928,300 American Depositary Shares on Nasdaq at US$6.83 per ADS, to raise approximately US$20 million (A$30.2 million) in gross proceeds, with a 45‑day option for underwriters to purchase additional ADSs to cover any over‑allotments. The capital injection, to be completed under the company’s existing ASX placement capacity and expected to close on 22 December 2025, will fund drilling, feasibility and environmental studies, camp expansion, permitting and initial development activities at its Estelle Gold and Critical Minerals Project in Alaska, as well as general corporate purposes, strengthening Nova’s ability to advance its flagship asset in a key North American gold and antimony province.
Nova Minerals Limited has requested an extension of its voluntary suspension of ordinary shares on the ASX as it prepares to announce a proposed capital raising and finalize the filing of a Form F-3 Registration Statement with the SEC in the USA. The suspension is expected to end on December 19, 2025, when the company anticipates making an announcement regarding the capital raising, which could impact its financial operations and market positioning.
Nova Minerals Limited has requested a voluntary suspension of its securities from quotation on the ASX, pending an announcement regarding a proposed capital raising. The suspension is expected to last until December 17, 2025, when the company anticipates making the announcement. This move is part of Nova’s strategic efforts to manage its financial operations and could impact its market positioning and stakeholder interests.
Nova Minerals Limited has requested a trading halt on its securities pending an announcement regarding a proposed share placement. This halt is expected to last until the announcement is made or until trading resumes on December 15, 2025. The company recently completed an exploration program and is awaiting assay results, which will be released once available. This move could impact Nova’s market positioning and stakeholder interests as it may influence the company’s financial strategies and future operations.
Nova Minerals Limited has announced the issuance of 1,714,286 fully paid shares following the exercise of unquoted options. This move is part of the company’s compliance with the Corporations Act, allowing for secondary trading exemption under section 708A. The announcement highlights Nova’s adherence to regulatory requirements and its ongoing exploration activities, with pending assay results from a recent exploration program expected to be released upon completion.
Nova Minerals Limited has announced the issuance of 1,714,286 fully paid ordinary securities to be quoted on the ASX, effective December 5, 2025. This move indicates the company’s strategic efforts to enhance its capital structure, potentially impacting its financial flexibility and market positioning.
Nova Minerals Limited announced the cessation of 8,250,000 securities due to the expiry of options without exercise or conversion as of November 30, 2025. This development may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s financial strategies and future growth potential.
Nova Minerals Limited has issued 43,500 fully paid shares following the exercise of US Warrants, alongside 3,625 American Depositary Shares to be traded on NASDAQ. This move, carried out under the secondary trading exemption of the Corporations Act, indicates Nova’s compliance with regulatory requirements and reflects ongoing developments in their exploration programs, with assay results pending that could impact future operations and investor assessments.
Nova Minerals Limited has announced the application for quotation of 43,500 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of the company’s ongoing efforts to expand its market presence and enhance its financial flexibility, which could potentially impact its stakeholders by increasing the liquidity of its shares and possibly attracting new investors.
Nova Minerals Limited has issued an update regarding a previous announcement about the application for quotation of securities. The update corrects the date of issue that was incorrectly stated in the earlier release. This adjustment ensures compliance with ASX listing rules and maintains transparency for stakeholders.
Nova Minerals Limited has announced the issuance of 120,000 fully paid shares following the exercise of US Warrants, along with 10,000 American Depositary Shares to be traded on NASDAQ. This move is part of a secondary trading exemption under the Corporations Act, allowing the sale of these shares without disclosure, as the company complies with necessary legal provisions. The announcement also mentions the completion of an exploration program, with pending assay results to be released once available, which could impact the company’s financial prospects and investor assessments.
Nova Minerals Limited has announced the issuance of 120,000 ordinary fully paid securities, set to be quoted on the Australian Securities Exchange (ASX) on November 18, 2025. This move is part of the company’s strategy to enhance its capital structure, potentially impacting its market positioning and offering new opportunities for stakeholders.
Nova Minerals Limited, listed on the Australian Securities Exchange under the code NVA, has announced an update regarding an error in the quantum of warrants to be issued. This update corrects a previous announcement made on November 11, 2025, and is crucial for stakeholders to ensure accurate information regarding the company’s unquoted equity securities.
Nova Minerals Limited has announced the issuance of 3,000,000 fully paid shares following the exercise of US Warrants, along with 250,000 American Depositary Shares to be traded on NASDAQ. This move is part of a secondary trading exemption under the Corporations Act, allowing the shares to be sold without disclosure. The company has recently completed an exploration program and is awaiting assay results, which could impact its financial and operational outlook.
Nova Minerals Limited has announced the issuance of 197,640 fully paid shares following the exercise of US Warrants, along with 16,470 American Depositary Shares (ADSs) to be traded on NASDAQ. This move is part of the company’s strategic financial operations to facilitate secondary trading exemptions under the Corporations Act 2001, allowing for the on-sale of securities without disclosure. The announcement also highlights the completion of an exploration program and the pending release of assay results, which could impact the company’s operational insights and future market positioning.
Nova Minerals Limited announced the application for quotation of 197,640 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of the company’s strategy to enhance its capital structure, potentially impacting its financial flexibility and market positioning positively.
Nova Minerals Limited announced that all resolutions proposed at their Annual General Meeting were passed, indicating strong shareholder support for the company’s strategic direction. The approval of resolutions, including the re-election of directors and the adoption of an employee incentive scheme, suggests a stable governance structure and potential for future growth, positively impacting stakeholders and reinforcing Nova’s position in the mining sector.
Nova Minerals has announced an increase in its Estelle Global Gold Mineral Resource Estimate to 9.9 million ounces of gold, reflecting significant progress in its exploration efforts. This development positions the company favorably within the mining industry, potentially enhancing its market value and attractiveness to investors, despite the inherent risks associated with mining operations and market fluctuations.
Nova Minerals has reached a pivotal stage in its operations at the Estelle Gold Project in Alaska, with significant advancements in both gold and antimony exploration. The company has completed a successful drilling program and received a substantial grant from the U.S. Department of War to develop a domestic antimony supply chain. With no debt and substantial funding, Nova is well-positioned to capitalize on the increasing demand for gold and critical minerals, aiming to enhance its industry standing and deliver economic benefits to Alaska.
Nova Minerals Limited has announced the issuance of 300,000 fully paid shares following the exercise of US Warrants, along with 25,000 American Depositary Shares to be traded on NASDAQ. This move is part of the company’s strategy to leverage secondary trading exemptions under the Corporations Act, enhancing its financial flexibility and market presence. The company is also awaiting assay results from a recent exploration program, which could impact its asset valuation and investor assessments.
Nova Minerals Limited has announced the issuance of 84,000 fully paid shares following the exercise of US Warrants, along with 7,000 American Depositary Shares to be traded on NASDAQ. This move is part of the company’s compliance with the Corporations Act, allowing secondary trading exemptions for these securities. The announcement indicates Nova’s ongoing exploration activities and its strategic financial maneuvers to enhance market positioning.
Nova Minerals Limited has announced the issuance of 84,000 new ordinary fully paid securities, which will be quoted on the ASX. This move is part of the company’s strategy to enhance its capital structure and potentially improve its market positioning, offering stakeholders an opportunity to engage with its growth prospects.
Nova Minerals has begun procuring essential mining and processing equipment for its Estelle antimony mining operations and refinery at Port Mackenzie, Alaska, with the goal of starting production by 2026/27. The company is bolstered by a US$43.4 million non-dilutive award from the U.S. Department of War, which supports its strategic objectives and positions Nova as a key player in the U.S. antimony supply chain. The procurement includes mining fleets, ore sorters, and processing infrastructure, with equipment scheduled for delivery in early 2026. Nova is also exploring partnerships to secure additional antimony supply and continues to advance its gold exploration projects, with an updated Mineral Resource Estimate forthcoming.
Nova Minerals has reported a robust financial position with access to over A$86.3 million in funding, including a significant award from the U.S. Department of War to boost antimony production in Alaska. The company has completed its 2025 drilling and exploration programs at the Estelle Project, which is gaining strong support from federal, state, and local stakeholders. This support is evidenced by high-level engagements with government officials and infrastructure projects like the West Susitna Access Road, which are crucial for unlocking the project’s full potential. The strategic importance of Nova’s assets is further validated by the U.S. Department of War’s endorsement and aligns with recent U.S. initiatives to reduce dependence on foreign imports of critical minerals.
Nova Minerals has announced updates on its projects, emphasizing the development of a tier one gold asset and securing domestic antimony supply in the U.S. This strategic move is expected to enhance the company’s market position and potentially increase its value, although it involves certain investment risks and uncertainties.
Nova Minerals Limited announced that its CEO, Christopher Gerteisen, will present at the Emerging Growth Conference, highlighting developments in the Estelle Gold and Critical Minerals Project in Alaska. The presentation will discuss the company’s strategy to advance its antimony assets and establish the first fully domestic antimony supply chain in the United States, following a recent $43.4 million award from the Department of War. This initiative positions Nova Minerals as a key player in the domestic antimony market, potentially impacting stakeholders by enhancing the company’s operational capabilities and market presence.
Nova Minerals Limited has issued 684,000 fully paid shares following the exercise of US Warrants and will also issue 11,400 American Depositary Shares to be traded on NASDAQ. This move is part of the company’s strategy to facilitate secondary trading exemptions under the Corporations Act, enhancing liquidity and investor access. The company recently completed an exploration program and is awaiting assay results, which could impact its financial performance and investor assessments once released.
Nova Minerals Limited has announced the quotation of 684,000 new ordinary fully paid securities on the Australian Securities Exchange (ASX), effective October 22, 2025. This move is part of the company’s strategy to enhance its capital structure, potentially impacting its market positioning and offering new opportunities for stakeholders.
Nova Minerals Limited has announced the issuance of 724,500 new ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX) under the code NVA. This move is part of the company’s strategy to capitalize on exercised options and convertible securities, potentially strengthening its financial position and market presence.
Nova Minerals Limited has announced the quotation of 702,240 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of October 17, 2025. This move is part of the company’s strategy to enhance its financial flexibility and support its ongoing projects, potentially strengthening its position in the mining sector and offering new opportunities for stakeholders.
Nova Minerals Limited has announced a forward split of its NASDAQ-listed American Depositary Shares (ADSs) to better align its US share price with industry peers and enhance liquidity. This strategic move is expected to attract a broader base of investors and strengthen Nova’s market presence as it progresses towards production of its gold and antimony assets.
Nova Minerals Limited has issued 2,363,940 fully paid shares following the exercise of unquoted underwriter US warrants and will also issue 39,399 American Depositary Shares to be traded on NASDAQ. This move, which aligns with the company’s compliance with the Corporations Act, aims to facilitate secondary trading exemptions and enhance liquidity. The company recently completed an exploration program and is awaiting assay results, which could impact its financial performance and investor assessments.
Nova Minerals Limited announced the quotation of 2,363,940 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of October 16, 2025. This move is part of the company’s strategy to strengthen its financial position and enhance its market presence, potentially impacting its operations and stakeholder interests positively.
Nova Minerals Limited has announced the issuance of 2,520,000 fully paid shares following the exercise of US Warrants, alongside 42,000 American Depositary Shares to be traded on NASDAQ. This move, facilitated under the Corporations Act’s secondary trading exemption, underscores Nova’s compliance with regulatory requirements and reflects its ongoing commitment to transparency and investor engagement. The company is also awaiting assay results from a recent exploration program, which could impact its operational outlook and investor assessments.
Nova Minerals Limited has announced the issuance of 1,202,880 fully paid shares following the exercise of US Warrants, alongside the issuance of 20,048 American Depositary Shares to be traded on NASDAQ. This move is part of a secondary trading exemption under the Corporations Act, allowing the on-sale of these securities without disclosure. The company has recently completed an exploration program and is awaiting assay results, which will be released upon completion. This development signifies Nova Minerals’ ongoing efforts to expand its financial base and enhance its market presence, potentially impacting its operations and stakeholder interests.
Nova Minerals Limited has announced the issuance of 1,202,880 ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX) under the code NVA. This move is part of the company’s strategy to leverage convertible securities, potentially impacting its financial structure and market presence by increasing liquidity and attracting new investors.
Nova Minerals has been invited to brief the Australian government ahead of a high-level meeting between Australian Prime Minister Anthony Albanese and U.S. President Donald Trump, highlighting the strategic importance of its Estelle Project. The project, located in Alaska’s Tintina Gold Belt, has received a US$43.4 million award from the U.S. Department of War, emphasizing its role in developing a domestic antimony supply chain. The planned antimony refinery at Port MacKenzie and the project’s inclusion on the U.S. Critical Minerals List underscore its significance in supporting U.S. defense and industrial needs, positioning Nova as a key player in the critical minerals sector.
Nova Minerals has secured a land use permit for an antimony refinery at Port MacKenzie, Alaska, as part of its strategy to establish a U.S. critical minerals hub. With a $43.4 million award from the U.S. Department of War, Nova plans to commence antimony production within 24 months, positioning itself as a key supplier in the U.S. antimony market. The company is negotiating further federal funding and has a first-mover advantage with secured land and government support. Nova is also working on offtake agreements and strategic partnerships to secure additional antimony supply, while progressing its gold deposits towards feasibility and production.
Nova Minerals Limited has issued 27,000 fully paid shares following the exercise of US Warrants and will also issue 450 American Depositary Shares to trade on NASDAQ. This move is part of their strategy to enhance liquidity and market presence, and they have ensured compliance with relevant regulatory requirements, while awaiting results from a recent exploration program.
Nova Minerals Limited has announced the issuance of 27,000 new ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX) under the code NVA. This move is part of the company’s strategy to enhance its financial flexibility and support its ongoing projects, potentially impacting its market positioning and offering new opportunities for stakeholders.
Nova Minerals Limited’s U.S. subsidiary, Alaska Range Resources LLC, has been awarded US$43.4 million by the U.S. Department of War to produce antimony trisulfide at the Estelle Project in Alaska. This funding will support the development of a domestic antimony supply chain, crucial for U.S. defense needs and industrial applications. The project aims to establish a state-of-the-art mining and refining hub, enhancing Nova’s industry positioning and contributing to the U.S. defense industrial base.
Nova Minerals Limited has issued 640,500 fully paid shares following the exercise of US Warrants and will also issue 10,675 American Depositary Shares to be traded on NASDAQ. This move is part of a secondary trading exemption under the Corporations Act, which allows the on-sale of these securities without disclosure. The company has recently completed an exploration program and is awaiting assay results, which could impact its financial position and future prospects.